Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Biomarkers and concussions
MDedge Cardiology
Samuel Shem: Part II
MDedge Cardiology
Trump rule and ACA contraception
MDedge Cardiology
Heart failure and sacubiril/valsartan
MDedge Cardiology
Vitamin D, fish out, and primary prevention
MDedge Cardiology
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Cardiology
Obesity curbs decades of CVD progress
MDedge Cardiology
AHA 2018: Part I
MDedge Cardiology
Physical fitness guidelines from HHS
MDedge Cardiology
Invasive strategy increased bleeding risk in frail older AMI patients
MDedge Cardiology